Found: 2
Select item for more details and to access through your institution.
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.
- Published in:
- Acta Neuropathologica, 2023, v. 145, n. 5, p. 651, doi. 10.1007/s00401-023-02566-0
- By:
- Publication type:
- Article
Average Temperature as a Marker of Lymphoma-Associated HLH.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 7, p. 455, doi. 10.1016/j.clml.2024.02.016
- By:
- Publication type:
- Article